Consistent with our results, HMGB1 was reported to be upregulated in both animal models of epilepsy and epileptic patients [29, 30], suggesting miRNA-mediated suppression of HMGB1 expression as a potential therapeutic strategy for SE-associated neuroinflammation and neurodegeneration. This evidence concerns the gene HMGB1 and epilepsy.